MK 2866
Ostarine MK-2866 is the most widely researched and clinically studied SARM in existence, with multiple Phase II human clinical trials investigating its efficacy for muscle wasting and osteoporosis. Its extensive research background provides a level of safety and pharmacokinetic understanding unmatched within the SARM category, making it the entry-point SARM of choice and the most commonly used compound for body recomposition.
Ostarine’s performance applications centre on its ability to simultaneously preserve or build lean muscle mass while supporting fat loss during caloric restriction — a recomposition effect that is particularly valuable during cutting phases where muscle preservation is critical. Its mild anabolic activity is accompanied by notable benefits for joint health and connective tissue repair.
MK-2866 is one of the least suppressive SARMs at standard doses, though PCT may still be warranted following cycles exceeding 8 weeks. Its versatility across bulking, cutting, and recomposition phases, combined with its favourable side effect profile and deep clinical research foundation, makes Ostarine the most accessible and broadly applicable SARM for athletes of all experience levels.
| Details | Information |
|---|---|
| API | Ostarine (MK-2866) |
| Strength | 25 mg |
| Format | Oral Capsules |
| Quantity | 30 Capsules |
| Category | SARM / Recomposition |
| Usage | Oral Use Only |
Disclaimer: Above mentioned information is for educational and reference purposes only. Consult a registered healthcare professional for a proper course of medication. These statements have not been evaluated by the Food and Drug Administration. This product shall only be available on a prescription from a registered healthcare professional.
Frequently Asked Questions
What is MK 2866?
What is MK 2866 commonly known for?
How is MK 2866 typically used?
Are there risks associated with MK 2866?
Can MK 2866 be used without medical supervision?
Is MK 2866 suitable for everyone?







Reviews
There are no reviews yet.